Cite
Eligibility for Cardiovascular Risk Reduction Therapy in the United States Based on SELECT Trial Criteria: Insights From the National Health and Nutrition Examination Survey.
MLA
Yuan Lu, et al. “Eligibility for Cardiovascular Risk Reduction Therapy in the United States Based on SELECT Trial Criteria: Insights From the National Health and Nutrition Examination Survey.” Circulation: Cardiovascular Quality & Outcomes, vol. 17, no. 1, Jan. 2024, pp. 82–84. EBSCOhost, https://doi.org/10.1161/CIRCOUTCOMES.123.010640.
APA
Yuan Lu, Yuntian Liu, Jastreboff, A. M., Khera, R., Ndumele, C. D., Rodriguez, F., Watson, K. E., & Krumholz, H. M. (2024). Eligibility for Cardiovascular Risk Reduction Therapy in the United States Based on SELECT Trial Criteria: Insights From the National Health and Nutrition Examination Survey. Circulation: Cardiovascular Quality & Outcomes, 17(1), 82–84. https://doi.org/10.1161/CIRCOUTCOMES.123.010640
Chicago
Yuan Lu, Yuntian Liu, Ania M. Jastreboff, Rohan Khera, Chima D. Ndumele, Fatima Rodriguez, Karol E. Watson, and Harlan M. Krumholz. 2024. “Eligibility for Cardiovascular Risk Reduction Therapy in the United States Based on SELECT Trial Criteria: Insights From the National Health and Nutrition Examination Survey.” Circulation: Cardiovascular Quality & Outcomes 17 (1): 82–84. doi:10.1161/CIRCOUTCOMES.123.010640.